Pacific Edge shares fall 63% after Novitas decision

Pacific Edge shares fall 63% after Novitas decision
(Image: Pacific Edge)
Rebecca Howard
Cancer diagnostics company Pacific Edge has come out swinging against a decision by Novitas, the Medicare administrative contractor with jurisdiction for its US laboratory, that would end reimbursement for Cxbladder Triage, Detect and Monitor. The shares fell 63% to $0.050 in early trading Monday after a trading halt was lifted.According to Pacific Edge, Novitas continues to misunderstand the current standard of care in evaluating hematuria patients, fails to consider new peer-reviewed evidence and repeats its flawed analysis of the existi...

More Markets

Woolworths NZ earnings rebound to $8.2b
Retail

Woolworths NZ earnings rebound to $8.2b

Woolworths has seen its NZ earnings grow to $8.29b.

'Predatory pricing': Govt targets supermarket market power
Retail

'Predatory pricing': Govt targets supermarket market power

Aldi and Lidl opted not to take part in the initial RFI.

Precinct looking for capital partners for PwC Tower
Property

Precinct looking for capital partners for PwC Tower

Precinct Properties wants to finance its last Commercial Bay development.

Meridian Energy slumps to $452 million net loss
Markets

Meridian Energy slumps to $452 million net loss

Meridian Energy slumped to a $452 million net loss in the June year, driven by a steep decline in its energy margins arising from two severe droughts.The company said its cash flow fell to $318m in the year, down from $667m in the previous year.The generator-retailer’s net loss c...